SEC Form 4 · accession 0000919574-19-001006
ALPINE IMMUNE SCIENCES, INC. · ALPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
TIGER MANAGEMENT L.L.C.
10% Owner
Period of report
Feb 8, 2019
Accepted (ET)
Feb 12, 2019 · 1:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626199
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 8, 2019 | S | 25,000 | $5.8498 | D | 137,728 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are held in the account of Tiger Partners Trading LLC which is wholly owned by Tiger Partners, L.P. and may be deemed to be beneficially owned by (a) Tiger Management L.L.C., the investment manager of Tiger Partners, L.P., and (b) Tiger Partners GP, LLC, the general partner of Tiger Partners, L.P. Each of Tiger Partners, L.P., Tiger Management L.L.C. and Tiger Partners GP, LLC disclaims beneficial ownership of these reported securities except to the extent of its pecuniary interest therein and affirmatively disclaims being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").